XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Non- Controlling Interest
Beginning balance (in shares) at Dec. 31, 2020   142,063,203        
Beginning balance at Dec. 31, 2020 $ 497,366 $ 1,421 $ 1,269,375 $ (777,981) $ 5,419 $ (868)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock in connection with at-the-market offering, net of offering expenses (in shares)   2,007,932        
Issuance of common stock in connection with at-the-market offering, net of offering expenses 27,099 $ 20 27,079      
Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax (in shares)   1,200,871        
Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax 1,594 $ 12 1,582      
Issuance of common stock under employee stock purchase plan (in shares)   244,570        
Issuance of common stock under employee stock purchase plan 2,054 $ 2 2,052      
Stock-based compensation 24,880   24,880      
Acquisition of additional shares of Sangamo France (134)   (70)     (64)
Foreign currency translation adjustment (6,006)       (6,006)  
Net pension gains 0          
Unrealized gain (loss) on marketable securities, net of tax (36)       (36)  
Buy-out of non-controlling interest (943)   (943)     943
Net loss (140,801)     (140,790)   (11)
Ending balance (in shares) at Sep. 30, 2021   145,516,576        
Ending balance at Sep. 30, 2021 406,016 $ 1,455 1,323,955 (918,771) (623) 0
Beginning balance (in shares) at Jun. 30, 2021   145,106,901        
Beginning balance at Jun. 30, 2021 445,457 $ 1,451 1,313,102 (871,083) 1,987 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock in connection with at-the-market offering, net of offering expenses (in shares)   202,705        
Issuance of common stock in connection with at-the-market offering, net of offering expenses 2,367 $ 2 2,365      
Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax (in shares)   206,970        
Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax 617 $ 2 615      
Stock-based compensation 7,873   7,873      
Foreign currency translation adjustment (2,565)       (2,565)  
Net pension gains 0          
Unrealized gain (loss) on marketable securities, net of tax (45)       (45)  
Net loss (47,688)     (47,688)   0
Ending balance (in shares) at Sep. 30, 2021   145,516,576        
Ending balance at Sep. 30, 2021 406,016 $ 1,455 1,323,955 (918,771) (623) $ 0
Beginning balance (in shares) at Dec. 31, 2021   145,921,530        
Beginning balance at Dec. 31, 2021 375,343 $ 1,459 1,334,138 (956,267) (3,987)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock in connection with at-the-market offering, net of offering expenses (in shares)   14,711,770        
Issuance of common stock in connection with at-the-market offering, net of offering expenses 66,448 $ 147 66,301      
Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax (in shares)   925,455        
Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax (1,838) $ 9 (1,847)      
Issuance of common stock under employee stock purchase plan (in shares)   359,468        
Issuance of common stock under employee stock purchase plan 1,115 $ 4 1,111      
Stock-based compensation 23,402   23,402      
Foreign currency translation adjustment (14,040)       (14,040)  
Net pension gains 130       130  
Unrealized gain (loss) on marketable securities, net of tax (1,101)       (1,101)  
Buy-out of non-controlling interest 0          
Net loss (140,305)     (140,305)    
Ending balance (in shares) at Sep. 30, 2022   161,918,223        
Ending balance at Sep. 30, 2022 309,154 $ 1,619 1,423,105 (1,096,572) (18,998)  
Beginning balance (in shares) at Jun. 30, 2022   153,352,502        
Beginning balance at Jun. 30, 2022 318,281 $ 1,534 1,373,324 (1,043,417) (13,160)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock in connection with at-the-market offering, net of offering expenses (in shares)   8,483,104        
Issuance of common stock in connection with at-the-market offering, net of offering expenses 42,174 $ 85 42,089      
Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax (in shares)   82,617        
Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax (101)   (101)      
Stock-based compensation 7,793   7,793      
Foreign currency translation adjustment (6,028)       (6,028)  
Net pension gains 55       55  
Unrealized gain (loss) on marketable securities, net of tax 135       135  
Net loss (53,155)     (53,155)    
Ending balance (in shares) at Sep. 30, 2022   161,918,223        
Ending balance at Sep. 30, 2022 $ 309,154 $ 1,619 $ 1,423,105 $ (1,096,572) $ (18,998)